CA2120967A1 - Medicine for the treatment of psoriasis and skin diseases - Google Patents

Medicine for the treatment of psoriasis and skin diseases

Info

Publication number
CA2120967A1
CA2120967A1 CA 2120967 CA2120967A CA2120967A1 CA 2120967 A1 CA2120967 A1 CA 2120967A1 CA 2120967 CA2120967 CA 2120967 CA 2120967 A CA2120967 A CA 2120967A CA 2120967 A1 CA2120967 A1 CA 2120967A1
Authority
CA
Canada
Prior art keywords
sodium chloride
psoriasis
skin
concentration
absolute
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2120967
Other languages
French (fr)
Inventor
Boubaker Boussetta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA 2120967 priority Critical patent/CA2120967A1/en
Publication of CA2120967A1 publication Critical patent/CA2120967A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A preparation for the treatment of : Psoriasis, psoriatiform Dermatosis, Seborreic dermatitis, dry lichenified Eczemas, Nevrodermites, pruritis, chronic dermatitis and any inflammatory skin disease. It may help in fungus, and dandruff.
It is particularly adapted to the treatment of psoriasis and any skin disease, very dry, rough, and with unattractive scaliness.
This product can avoid recurrences of acute exacerbations of skin diseases.
It can be used on the scalp, including post auricular regions, and remove thick scalp plaques, difficult to treat.
It is also effective as ear drops.
It can serve also for cleansing, soothing, softening and moisturizing the skin.
This medicament is basically comprising a mixture of :
1 - Absolute Jasmin Oil.
2 - A hypertonic water solution of Sodium chloride.
3 - Salicylic Acid, in a 4 - Colloidal silica carrier.
5 - Antiseptic Agent.
The first three ( 3 ) ingredients represent the active element of this product.
Absolute Jasmin oil in a concentration of 33 to 50 %.
Salted Water is added, with a hypertonic concentration of Sodium chloride, much higher than the physiological concentration of Sodium chloride in the human blood.
Salicylic Acid, Colloidal Silica, and Antiseptic material are also included.
The composition is applied and frictioned gently and should be applied only after bathing.
It also provides a refreshing and soothing effect.
It can be used also as a cosmetic.
The form is an emulsion, a liquid cream, or a cream.

Description

2 /~

This invention relates to a process for removing and clearing away the skin scales, cicatrizing, healing and soothing the skin.
The product consists esentially of a liquid or a cream in which the active element is a hypertonic aqueous solution of Absolute Jasmin oil and Salicylic Acid, in a colloidal silica carrier.

1 - The Jasmin oil is preferably used in the form of Jasmine Absolute such as exists in commerce under the common name of " Chambeli ".
This is an essential oil extacted from the extremely fragrant flowers of Jasmine.
It is also a natural perfume material which is not subjected to heat.
The term " Absolute " means a plant-extracted material that has been concentrated, but that remains absolutely unchanged in its original taste and odor.
Its concentration should be from 33 to 50 percent.
2 - Salted Water is added, in a hypertonic concentration of Sodium chloride, higher than the physiological concentration of Sodium chloride in the human blood.
Best effects are obtained with sodium chloride in the combination of a mineral, thermal purified spring water.
Sodium is also used as a second barrier agent.
Sodium concentration should be from 5 to 10 percent.
3 - The absorbent medium in which the solution of Jasmine oil and Sodium chloride are incorporated is Silicon Dioxide or silica in its colloidal form. The most adequate is "Aerosil", the most appropriate for the preparation of this medicine.
The relative proportion of silica to be used is up to 5% for liquid cream, or an emulsion, and up to 10 %
for a stiffer cream.
It acts as a barrier agent.
We don't need a skin protective ingredient, because Jasmin Oil represents a good protection.
These components compounded in this manner produces, when applied to the skin conditions, especially cutaneous wounds and scales, produce, through the evident results, and according to medical data, an " Exosmotic " effect on the underlying tissues.
There is a reason to believe thot a reversed direction osmotic action, directed form the underlying tissues to the exterior, the outside milieu.
This Exosmotic effect produces an aspiration of the tissues liquid to the exterior milieu.
This effect is explained by the medical effects of all hypertonic liquids and fluids in medicine.

21209fi7 This combination acts like an absorbing exudate material.
In medical words, it seems to be that this product has a higher proportion of ions per unit of volume compared to that of the human blood. And this is confirmed by the pH variations of liquids.
A healing and soothing effect are produced when this product is applied and for a long time, from 2 to 7 days, depending on the frequency of washing or bathing.
On the other hand, the healing effect produced by this medicine shows that it acts as a keratolytic, stopping the continuous proliferation of the skin cornea stratum, while the soothing effect produced by this medicine shows that the aspiration of the body tissues liquid may extract big quantities of tissue liquid, through this inverted osmose, (Exosmosis).
4 - Salicylic Acid is then added as :
- A keratolytic medicine at 2 to 10 percent concentration acting like a crude coal tar or Anthralin ( Dithranol ), without the indesirable odor of the coal tar, or its risks to cause cancer and allergic reactions.
Anthralin ( Dithranol ) also may cause rash and intensify chronic kidney diseases.
Also, it does not stain sheets and clothing, while Anthralin does.
- Antimicrobial medicine at 2 to 5 percent concentration in lotions and ointments, and at 0.1 to 0.5 percent in skin softeners and hair tonics, dandruff preparations and protective creams.
- Antipyretic, antifever medicine.
- It is Antipuretic ~anti-itching).
- Anti-inflammatory agent.
- Antiseptic.
- Analgesic.
Absorbed throught the skin, it rarely causes skin rashes.
For our medicament, the concentration should be from 2 to 5 percent.
This Medicament can be used on the scalp, including post auricular regions, and will remove thick scalp plaques, difficult to treat, mostly if we add more than 1 % of this ingredient in this oily Sodium Chloride hypertonic solution.
5 - While it may rarely cause small allergic reactions, we do added :
Benzocaine or Ethyl Aminobenzoate :
A local anesthetic, very low in toxicity.
All scientists confirm that no toxic significance is related even to concentrations of this product.

212~967 -(It is Better to avoid in babies due to its lowering oxygene effect in blood, creating a methemoglobinemia due to its absorption through the skin in case of inflamed skin or rectal fissures).
With this ingredient, the medicament is hypoallergic, and is least likely to cause a reaction.
Its concentration should be from .1 to .5 percent.
6 - Preservatives may also be added to the colloidal solution or liquid cream such as : Sorbic Acid.
7 - Other Bacteriostatic compounds, and antiseptics can also be added.
With these additions, the composition of our product is as follows :
Absolute Jasmin oil : 33 to 50% preferably 40%
For Hypertonic water solution, Sodium chloride : 05 to 10% preferably05%
Colloidal silica, Aerosil : 05 to 10% preferably08%.
Salicylic Acid : 02 to 05% preferably03%.
Benzocaine or Ethyl Aminobenzoate : .~ to .5% preferably .2%
Preservatives, such as Sorbic Acid. : Trace.
Other Bacteriostatic compounds, and antiseptics : .2 to .5% preferably .5%
Water : Q.S. to 100%
The composition is prepared by starting with :
1 - Hypertonic water solution of Sodium chloride is prepared.
2 - Then the colloidal silica is dispersed into this solution.
3- Then heating gently and adding all other substances :
Salicylic Acid, and others.
4 - Then we stop heating and add :
Benzocaine or Ethyl Aminobenzoate, Preservatives, Other Bacteriostatic compounds, and antiseptics, Absolute Jasmin oil, and Water.
This way, we obtain an emulsion of oil - water type.
The first essential component acts as follows :
1 - A keratolytic medicine, acting like a crude coa~
tar or Anthralin ( Dithranol ).
2 - It is Antipuretic (anti-itching).

2120g67 3 - Anti-inflammatory agent.
4 - As a barrier agent, it represents a good protection.
5 - As a lubricant oil, hydrogenated vegetable oil, it prevents, with its hygroscopic fatty substances components, a very rapid drying which could be detrimental to the exosmotic effect.
6 - With its greasing effect, it prevents desiccation and fissurization of the skin, 7 - Promotes the moisturizing effect of the emulsion.
The water makes the solution easier to friction, and better milieu to hold Sodium Chloride, producing also a very soothing effect on the skin.
The water produces also a refreshing effect through a light evaporation and mostly through the exosmosis.
It is important that water be antisepticized to avoid contamination of the product.
The Colloidal Silica, Aerosil, should hold the salt solution.
Also it is possible to add as a thickener :
1. "Carboxymethyl Cellulose", or 2. Hydroxymethylcellulose, as a good thickener and bodying agent derived from plants, used in all oriental and arabic world as a setting aid in hair.
Examples of Compositions Grams Percent No 1.Absolute Jasmin oil : 40 40 For Hypertonic water solution, Sodium chloride : 05 05 Colloidal silica, Aerosil : 08 08 Salicylic Acid : 03 03 Benzocaine or Ethyl Aminobenzoate : .2 .2 Preservatives, such as Sorbic Acid. : Trace.
Other Bacteriostatic compounds, and antiseptics : .5 .5 Water : Q.S. to 100%

No 2.
Absolute Jasmin oil : 50 50 For Hypertonic water solution, Sodium chloride : 05 05 Colloidal silica, Aerosil : 08 08 Salicylic Acid : 03 03 Benzocaine or Ethyl Aminobenzoate : .2 .2 Preservatives, such as Sorbic Acid. : Trace.
Other Bacteriostatic compounds, and antiseptics : .5 .5 Water : Q.S. to 100%
No 3.
Absolute Jasmin oil : 33 33 For Hypertonic water solution, Sodium chloride : 05 05 Colloidal silica, Aerosil : 08 08 Salicylic Acid : 04 04 Benzocaine or Ethyl Aminobenzoate : .2 .2 Preservatives, such as Sorbic Acid. : Trace.
Other Bacteriostatic compounds, and antiseptics : .5 .5 Lanolin 3.0 2.0 Sorbic Acid 0.2 Trace Water : Q.S. to 100%
When used after bath, the result is relatively accelerated.
It is advised to clean it with water after 48 hours only.
Repeated application during 5 to 10 Days, even without washing, procures a better improvement.

Claims (5)

1 - A process for :
Treating : Psoriasis, and other dermatological diseases, such as psoriatiform Dermatosis, Seborreic dermatitis, dry lichenified Eczemas, Nevrodermites, pruritis, chronic dermatitis and any inflammatory skin disease.
It may help in fungus, and dandruff.
This medicament consists essentially of :
Percent 1. Absolute Jasmin oil : 33 to 50%
2. Sodium chloride, : 05 to 10%
for Hypertonic water solution.
3. Salicylic Acid : 02 to 05%
4. A member selected from the group of absorbent material silica : 05 to 10%
This combination with or without
5. Benzocaine or Ethyl Aminobenzoate : .1 to .5%
CA 2120967 1994-04-11 1994-04-11 Medicine for the treatment of psoriasis and skin diseases Abandoned CA2120967A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2120967 CA2120967A1 (en) 1994-04-11 1994-04-11 Medicine for the treatment of psoriasis and skin diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2120967 CA2120967A1 (en) 1994-04-11 1994-04-11 Medicine for the treatment of psoriasis and skin diseases

Publications (1)

Publication Number Publication Date
CA2120967A1 true CA2120967A1 (en) 1995-10-12

Family

ID=4153344

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2120967 Abandoned CA2120967A1 (en) 1994-04-11 1994-04-11 Medicine for the treatment of psoriasis and skin diseases

Country Status (1)

Country Link
CA (1) CA2120967A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1364640A1 (en) * 2002-05-24 2003-11-26 Sebapharma GmbH & Co. KG Pharmaceutical composition with anti-swelling effect on the skin
US7670620B2 (en) * 2000-05-01 2010-03-02 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
WO2016024875A1 (en) * 2014-08-11 2016-02-18 Matonis Grzegorz Cosmetic and/or pharmaceutical formulation soothing symptoms of psoriasis
WO2016162640A1 (en) * 2015-04-09 2016-10-13 Concept Salt gel and use thereof in preventing and treating parasitoses and skin disorders

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7670620B2 (en) * 2000-05-01 2010-03-02 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
EP1364640A1 (en) * 2002-05-24 2003-11-26 Sebapharma GmbH & Co. KG Pharmaceutical composition with anti-swelling effect on the skin
WO2016024875A1 (en) * 2014-08-11 2016-02-18 Matonis Grzegorz Cosmetic and/or pharmaceutical formulation soothing symptoms of psoriasis
WO2016162640A1 (en) * 2015-04-09 2016-10-13 Concept Salt gel and use thereof in preventing and treating parasitoses and skin disorders
FR3034666A1 (en) * 2015-04-09 2016-10-14 Concept SALT GEL AND ITS USE IN THE PREVENTION AND TREATMENT OF PARASITOSES AND DERMATOLOGICAL DISEASES

Similar Documents

Publication Publication Date Title
CA1157380A (en) Preparations containing methylsulfonylmethane and methods of use and purification
US4788060A (en) Multiple electrolyte douche and wipe composition
JP4010574B2 (en) Topical skin preparation
JPH04139125A (en) Dermal external preparation for acne vulgaris
WO2011119247A2 (en) Topical skincare composition
FI82598C (en) COSMETIC COMPOSER AVSEDDA FOER UTVAERTESBRUK.
JP2651992B2 (en) Bath additive
JPH0768114B2 (en) Bath additive
JPH08245409A (en) Skin preparation for external use and bathing agent
CA2120967A1 (en) Medicine for the treatment of psoriasis and skin diseases
JP3645318B2 (en) Anti-aging skin external preparation
JPH09221410A (en) Aging preventing skin ointment
JPS5976007A (en) Cosmetic
US9827176B2 (en) Antifungal deodorant
BRPI1101172A2 (en) deodorant and antiperspirant composition, process for producing deodorant and antiperspirant composition and method for the prevention and / or reduction of perspiration odors
CN105411934A (en) Waterless oil type cleaning cream containing liquorice
JPS60152415A (en) Remedy for pimple and pharmaceutical preparation for remedying pimple consisting of carrier impregnated therewith
CN109876107A (en) A kind of antipruritic Chinese medicine composition of natural antibacterial and application thereof
RU2712790C1 (en) Modulating shampoo for hair and skin care of scalp and method for production thereof
JPH0755900B2 (en) Acne vulgaris remedy
RU2170094C1 (en) Biologically active addition for cosmetic and curative-prophylactic articles
RU2158143C1 (en) Antiseptic liquid "veltaleks-m"
JP2004307372A (en) External preparation for acne, use of plum extract and germicidal and antibacterial agent
CN114948830A (en) Functional medical cleaning wet tissue liquid for human body
RU2114607C1 (en) Treatment-and-hygiene and cosmetic emulsion "troya" for skin care

Legal Events

Date Code Title Description
FZDE Dead